These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8130765)

  • 41. Fluorophore-assisted carbohydrate electrophoresis for the determination of molecular mass of heparins and low-molecular-weight (LMW) heparins.
    Buzzega D; Maccari F; Volpi N
    Electrophoresis; 2008 Nov; 29(20):4192-202. PubMed ID: 18844319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of chemical and structural features of low molecular weight heparins (LMWHs) on skin penetration.
    Franzè S; Gennari CG; Minghetti P; Cilurzo F
    Int J Pharm; 2015 Mar; 481(1-2):79-83. PubMed ID: 25655714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent Developments in the Separation of Low Molecular Weight Heparin Anticoagulants.
    Sadowski R; Gadzała-Kopciuch R; Buszewski B
    Curr Med Chem; 2019; 26(1):166-176. PubMed ID: 28982317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive Identification and Quantitation of Basic Building Blocks for Low-Molecular Weight Heparin.
    Sun X; Sheng A; Liu X; Shi F; Jin L; Xie S; Zhang F; Linhardt RJ; Chi L
    Anal Chem; 2016 Aug; 88(15):7738-44. PubMed ID: 27388010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy.
    Guerrini M; Guglieri S; Naggi A; Sasisekharan R; Torri G
    Semin Thromb Hemost; 2007 Jul; 33(5):478-87. PubMed ID: 17629844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.
    Schroeder M; Hogwood J; Gray E; Mulloy B; Hackett AM; Johansen KB
    Anal Bioanal Chem; 2011 Jan; 399(2):763-71. PubMed ID: 20922518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel method for the determination of average molecular weight of natural polymers based on 2D DOSY NMR and chemometrics: Example of heparin.
    Monakhova YB; Diehl BWK; Do TX; Schulze M; Witzleben S
    J Pharm Biomed Anal; 2018 Feb; 149():128-132. PubMed ID: 29112901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array.
    Bertini S; Bisio A; Torri G; Bensi D; Terbojevich M
    Biomacromolecules; 2005; 6(1):168-73. PubMed ID: 15638517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies on polysaccharide peptide with high performance gel permeation chromatography].
    Zhang Z; Yang X; Fang J
    Se Pu; 1997 Mar; 15(2):150-2. PubMed ID: 15739407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Semisynthesis and analysis of lipophilically modified unfractionated and low molecular mass heparins.
    Malsch R; Harenberg J; Guerrini M; Torri G; Casu B; Heene DL
    Semin Thromb Hemost; 1994; 20(2):182-92. PubMed ID: 7997890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin.
    Crowther MA; Berry LR; Monagle PT; Chan AK
    Br J Haematol; 2002 Jan; 116(1):178-86. PubMed ID: 11841415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes.
    Akhtar F; Wan X; Wu G; Kesse S; Wang S; He S
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30021958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation of tea glycoprotein and its application as a calibration standard for the quantification and molecular weight determination of tea glycoprotein in different tea samples by high-performance gel-permeation chromatography.
    Nie S; Xie M; Wang Y
    Anal Bioanal Chem; 2005 Oct; 383(4):680-6. PubMed ID: 16184368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Low-Molecular-Weight Heparins by Strong Anion-Exchange Chromatography.
    Sadowski R; Gadzała-Kopciuch R; Kowalkowski T; Widomski P; Jujeczka L; Buszewski B
    J AOAC Int; 2017 Nov; 100(6):1706-1714. PubMed ID: 28707621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liquid chromatography-diode array detection-mass spectrometry for compositional analysis of low molecular weight heparins.
    Wang Z; Li D; Sun X; Bai X; Jin L; Chi L
    Anal Biochem; 2014 Apr; 451():35-41. PubMed ID: 24530286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preserving the original heparin structure of a novel low molecular weight heparin by gamma-irradiation.
    Bisio A; De Ambrosi L; Gonella S; Guerrini M; Guglieri S; Maggia G; Torri G
    Arzneimittelforschung; 2001 Oct; 51(10):806-13. PubMed ID: 11715633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Competitive inhibition of myosin ATPase activity by different molecular weight heparins.
    Volpi N; Bianchini P; Bolognani L
    Biochem Int; 1991 May; 24(2):243-53. PubMed ID: 1656981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An approach to a molecular weight calibration for low molecular weight heparins.
    Johnson EA
    Thromb Res; 1987 Mar; 45(5):675-80. PubMed ID: 3590094
    [No Abstract]   [Full Text] [Related]  

  • 59. Ultra-low-molecular-weight heparins: precise structural features impacting specific anticoagulant activities.
    Lima MA; Viskov C; Herman F; Gray AL; de Farias EH; Cavalheiro RP; Sassaki GL; Hoppensteadt D; Fareed J; Nader HB
    Thromb Haemost; 2013 Mar; 109(3):471-8. PubMed ID: 23329070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New data on the pharmacology of heparin and low molecular weight heparins.
    Samama MM; Bara L; Gouin-Thibault I
    Drugs; 1996; 52 Suppl 7():8-14; discussion 14-5. PubMed ID: 9042555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.